-+ 0.00%
-+ 0.00%
-+ 0.00%

JASPER THERAPEUTICS INC: BRIQUILIMAB WAS WELL TOLERATED IN STUDY, DEMONSTRATING A FAVORABLE SAFETY PROFILE

Reuters·12/02/2025 12:00:03

Please log in to view news